
9th APP, Nursing and Primary Care Liver Conference
April 11 @ 7:15 am – 4:45 pm
The conference will focus on highlighting new standards in diagnosis and clinical management of liver diseases for the non-liver specialist. The educational format includes lectures, case studies and panel discussion.

Embassy Suites by Hilton San Antonio-Landmark
5615 Landmark Pkwy
San Antonio, TX 78249
| TIME | TOPIC |
|---|---|
| 7:15-8:15 AM | Breakfast |
| 7:30-8:15 AM | Evolving Approach to Second-Line Treatment in PBC (David Victor, MD) (Non-accredited) |
| Welcome (Co-chairs: Kelleah Powao, NP/Jessica Jennings, NP) | |
| 8:15-8:25 AM | Welcome and conference objectives |
| Session I: Fatty Liver Disease (Moderator: Toluwalase Okubote, MD) | |
| 8:25-8:45 AM | When is Fatty Liver Disease Worrisome? (Krishna Venkata, MD) |
| 8:45-9:05 AM | Treatment Updates in MASH (Maribel DePonce, PA) |
| 9:05-9:25 AM | Alcohol’s Effects on the Liver (Jan Petrasek, MD, PhD) |
| 9:25-9:45 AM | The Benefits of Clinical Research: Bringing Tomorrow’s Drugs to Patients Today (Toluwalase Okubote, MD) |
| 9:45-10:00 AM | Discussion/Q&A |
| 10:00-10:15 AM | Break |
| Session II: Autoimmune and Genetic Liver Diseases (Moderator: Jessica Jennings, NP) | |
| 10:15-10:35 AM | Primary Biliary Sclerosis (PBC): Diagnosing and Positioning New Treatments (Arianna Garcia, PA) |
| 10:35-11:00 AM | Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH): What You Need to Know (Katherine Wilks, PA) |
| 11:00-11:25 AM | Recognizing and Treating Genetic Liver Diseases (Jessica Jennings, NP) |
| 11:25-11:50 AM | Primary Care’s Important Role in the Management of These Chronic Diseases (Steven Fierro, NP) |
| 11:50 AM-12:05 PM | Discussion/Q&A |
| 12:05-1:05 PM | Lunch/Product Theater |
| 12:15-1:00 PM | Product Theater (Sponsor: Gilead Sciences) |
| Session III: Cirrhosis (Moderator: Kelleah Powao, NP) | |
| 1:05-1:30 PM | Progression of Liver Disease from Fibrosis to Cirrhosis (Kathy Crow, PA) |
| 1:30-1:55 PM | Managing Complications of Cirrhosis: Hepatic Encephalopathy (HE), Hepatorenal Syndrome (HRS) and Ascites (Kelleah Powao, NP) |
| 1:55-2:20 PM | Chronic Hepatitis C (HCV) and Cirrhosis Case Study (Heather Ritter, NP) |
| 2:20-2:35 PM | Discussion/Q&A |
| 2:35-2:45 PM | Break |
| Session IV: Advancements in Liver Disease Management (Moderator: Mark Dedmon, PA) | |
| 2:45-3:10 PM | Liver Cancers: Current and Emerging Practices (Abdurrahman Kadayifci, MD) |
| 3:10-3:35 PM | Positioning Therapies for Liver Cancers (Sidart Pradeep, MD) |
| 3:35-4:00 PM | Who Qualifies for Living Donor Liver Transplant: Donor and Recipient (Eugenia Tsai, MD) |
| 4:00-4:20 PM | Living Donor Liver Transplant: Managing the Donor and Recipient Post Transplant (Mark Dedmon, PA) |
| 4:20-4:35 PM | Discussion/Q&A |
| 4:35-4:45 PM | Summary/Wrap up |
Conference Sponsors
Diamond Sponsors

Platinum Sponsor

Gold Sponsors





